Drug recall
Red Blood Cells, Leukocytes Reduced
FDA recall event 91461 · Class II · American Red Cross Greater Alleghenies Region
Key facts
| Event ID | 91461 |
|---|---|
| Recall numbers | B-0140-2023 |
| Recalling firm | American Red Cross Greater Alleghenies Region |
| Product type | Biologics |
| Products | Red Blood Cells, Leukocytes Reduced |
| Classification | Class II |
| Status | Terminated |
| Voluntary or mandated | Voluntary: Firm Initiated |
| Reason for recall | Leukoreduced Red Blood Cells, which initially tested RPR reactive for syphilis, but had no confirmatory testing, were distributed. |
| Initiation date | Jul 20, 2022 |
| Report date | Jan 25, 2023 |
| Termination date | Jan 18, 2023 |
| City | Johnstown |
| State | PA |
| Country | United States |
| FEI number | 2573016 |
At a glance
- 1–9 Products in this recall
- 10–99 FDA inspections of this firm (FEI)
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA drug and product recalls
FDA enforcement reports list recalls of drugs, biologics, foods and other FDA-regulated products, classified by the potential health hazard.
Source: U.S. Food and Drug Administration (FDA), Enforcement Reports · Source date: